Financial Times analysis examines efforts to address dual risk research

A Financial Times analysis examines how the international community is working "to ensure scientific work can proceed without falling prey to accidental leaks or malevolent intent," following controversy surrounding two studies on the H5N1 bird flu virus. The article states that "while much discussion has focused on the 'virtual' leakage of such studies through the very fact of publication, allowing the unscrupulous to read and replicate the work, another important risk has received far less attention: the accidental 'physical' leakage from the growing number of laboratories en­gaged in such work around the world." The article describes several accidental leaks and how governments and international bodies are working to balance risk and regulation (Jack, 4/10).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New research explores how antimicrobial exposure affects Parkinson’s disease risk